Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2026-03-04 @ 10:12 PM
Study NCT ID:
NCT02378935
Status:
COMPLETED
Last Update Posted:
2020-03-06
First Post:
2015-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-02-17
Start Date Type:
ACTUAL
Primary Completion Date:
2016-02-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-12
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-27
First Submit QC Date:
None
Study First Post Date:
2015-03-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-16
Results First Submit QC Date:
None
Results First Post Date:
2017-12-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-06-06
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-02-18
Last Update Post Date:
2020-03-06
Last Update Post Date Type:
ACTUAL